ArticleEuropean archives of psychiatry and clinical neuroscience2026
Thyroid hormones and cognitive function in chronic schizophrenia: a large-scale cross-sectional study.
Article in European archives of psychiatry and clinical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundCognitive dysfunction is a core symptom in chronic schizophrenia, yet the mechanisms underlying these impairments remain poorly understood. Thyroid hormones have been suggested to influence cognitive function in various psychiatric disorders, but their role in schizophrenia remains unclear. This study aimed to explore the relationship between thyroid hormone levels and cognitive performance in patients with chronic schizophrenia.
methodsA total of 1271 patients with chronic schizophrenia were included in this cross-sectional study. Cognitive function was assessed using the repeatable battery for the assessment of neuropsychological status (RBANS), while thyroid hormone levels (total triiodothyronine (TT3), total thyroxine (TT4), free triiodothyronine (FT3), and free thyroxine (FT4)) were measured. Data analysis included linear correlation and regression models to examine the relationships between thyroid hormones and cognitive performance.
resultsSignificant associations were found between thyroid hormone levels and cognitive function. FT3 was positively correlated with visuospatial (r = 0.055, p < 0.05), while TT4 showed a negative correlation with immediate memory, visuospatial, language, and attention (r = -0.109 to -0.068, p < 0.05). Regression analysis further confirmed that TT4 was a negative predictor for immediate memory, visuospatial, language, and attention, while FT3 emerged as a positive predictor for visuospatial.
conclusionsThis study provides evidence for the role of thyroid hormones in cognitive dysfunction in chronic schizophrenia, with TT4 negatively related to multiple cognitive domains, and FT3 positively associated with visuospatial ability. These findings suggest that thyroid hormone imbalances may contribute to cognitive impairments in schizophrenia and warrant further investigation into potential therapeutic interventions.
Indexed as
Identifiers
40828420What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.